|
Mutation Information
|
Mutation Site
|
Y38F |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
C |
|
Genotype/Subtype
|
A |
|
Viral Reference
|
X02763
|
|
Relevant Drug
|
JNJ‐6379 |
|
Country
|
Asia‐Pacific;Europe |
Literature Information
|
PubMed PMID
|
32579776
|
|
Disease
|
Chronic hepatitis B
|
|
Published Year
|
2020 |
|
Journal
|
Journal of viral hepatitis |
|
Title
|
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy. |
|
Author
|
Verbinnen T,Hodari M,Talloen W,Berke JM,Blue D,Yogaratnam J,Vandenbossche J,Shukla U,De Meyer S,Lenz O |
|
Evidence
|
One 75 mg JNJ‐6379‐treated patient (GT‐C, HBeAg‐negative) had emerging Y38F and T109S (FC = 1.4 and 1.8, respectively) as major variants at the end of follow‐up visit week 12 (8 weeks after the end of JNJ‐6379 treatment)
|
|
|
HBV Mutation Detail Information